A distinct epigenetic signature at targets of a leukemia protein
暂无分享,去创建一个
Stefano Rossetti | Peter van der Spek | P. J. van der Spek | A. Hoogeveen | N. Sacchi | Ping Liang | P. Liang | Nicoletta Sacchi | S. Rossetti | Cornel Stanciu | André T Hoogeveen | Cornel Stanciu | Stefano Rossetti
[1] Daiya Takai,et al. The CpG Island Searcher: A new WWW resource , 2003, Silico Biol..
[2] T. Iwakuma,et al. Organization and expression of the mouse gene for DNA repair methyltransferase. , 1996, DNA and cell biology.
[3] M. Lübbert,et al. Upstream and downstream targets of RUNX proteins , 2003, Journal of cellular biochemistry.
[4] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] Charles Elkan,et al. Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer , 1994, ISMB.
[6] T. Evans. Regulation of hematopoiesis by retinoid signaling. , 2005, Experimental hematology.
[7] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[8] T. Nagase,et al. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. , 1998, Blood.
[9] J. Herman,et al. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer , 2004, Oncogene.
[10] Z. Dauter,et al. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. , 2006, Cancer cell.
[11] A. Hoogeveen,et al. The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies , 2002, Oncogene.
[12] J. Kinet,et al. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. , 1999 .
[13] François Fuks,et al. DNA methylation and histone modifications: teaming up to silence genes. , 2005, Current opinion in genetics & development.
[14] S. Gerson. MGMT: its role in cancer aetiology and cancer therapeutics , 2004, Nature Reviews Cancer.
[15] M. Ohki,et al. Interaction and functional cooperation of the leukemia‐associated factors AML1 and p300 in myeloid cell differentiation , 1998, The EMBO journal.
[16] Michael C. Ostrowski,et al. TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. , 1999, Journal of immunology.
[17] Yoshiaki Ito,et al. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2 , 1999, Oncogene.
[18] P. Boccuni,et al. Transcription factor fusions in acute leukemia: variations on a theme , 2002, Oncogene.
[19] C. Peterson,et al. Histones and histone modifications , 2004, Current Biology.
[20] T. Kouzarides. Histone methylation in transcriptional control. , 2002, Current opinion in genetics & development.
[21] H. Drabkin,et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.
[22] J. Downing,et al. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions , 1993, Molecular and cellular biology.
[23] S. Pozzi,et al. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk. , 2006, Cancer research.
[24] S. Nakamura,et al. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. , 2000, Blood.
[25] J. Altin,et al. The role of CD45 and CD45‐associated molecules in T cell activation , 1997, Immunology and cell biology.
[26] S. Minucci,et al. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. , 2000, Molecular cell.
[27] H. Shimada,et al. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis , 2002, Leukemia.
[28] M. Ohki,et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] The Partner Gene of AML1 in t(16;21) Myeloid Malignancies Is a Novel Member of the MTG8(ETO) Family , 1998 .
[30] P. Watkins,et al. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. , 1992, Cancer genetics and cytogenetics.
[31] C. Allis,et al. Translating the Histone Code , 2001, Science.
[32] S. Hiebert,et al. Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins , 2001, Current opinion in hematology.
[33] I. Touw,et al. Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation , 2005, Oncogene.
[34] T. Kouzarides,et al. DNA methyltransferases get connected to chromatin. , 2002, Trends in genetics : TIG.
[35] Hamish S Scott,et al. AML1 Interconnected Pathways of Leukemogenesis , 2003, Cancer investigation.
[36] O. Heidenreich,et al. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts , 2006, Oncogene.
[37] S. Minucci,et al. Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.
[38] J. Herman,et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia , 2005, Annals of Hematology.
[39] S. Coughlin,et al. Thrombin signalling and protease-activated receptors , 2000, Nature.
[40] A. Rosmarin,et al. Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, myeloid differentiation, and leukemogenesis. , 2005, Experimental hematology.
[41] Natalia Meani,et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. , 2003, The Journal of clinical investigation.
[42] B. Hug,et al. Oligomerization of ETO Is Obligatory for Corepressor Interaction , 2001, Molecular and Cellular Biology.
[43] S. Berger,et al. Histone modifications in transcriptional regulation. , 2002, Current opinion in genetics & development.
[44] T. Yamagata,et al. Runx1/AML1 in Normal and Abnormal Hematopoiesis , 2005, International journal of hematology.
[45] Y. Ito,et al. Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Hoogeveen,et al. The MTG proteins: chromatin repression players with a passion for networking. , 2004, Genomics.
[47] S. Pozzi,et al. RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells , 2006, Oncogene.
[48] D. Hume,et al. Transcription Factor Tfec Contributes to the IL-4-Inducible Expression of a Small Group of Genes in Mouse Macrophages Including the Granulocyte Colony-Stimulating Factor Receptor1 , 2005, The Journal of Immunology.